YD Bio Limited (NASDAQ:YDES – Get Free Report)’s stock price dropped 4.4% during mid-day trading on Wednesday. The stock traded as low as $6.80 and last traded at $7.2760. 68,234 shares changed hands during trading, a decline of 52% from the average daily volume of 141,640 shares. The stock had previously closed at $7.61.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised YD Bio to a “hold” rating in a research note on Saturday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Read Our Latest Report on YDES
YD Bio Price Performance
YD Bio (NASDAQ:YDES – Get Free Report) last posted its earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million during the quarter.
Hedge Funds Weigh In On YD Bio
A hedge fund recently raised its position in YD Bio stock. Cypress Capital Management LLC WY boosted its holdings in shares of YD Bio Limited (NASDAQ:YDES – Free Report) by 9.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent quarter.
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Featured Articles
- Five stocks we like better than YD Bio
- 3 Healthcare Dividend Stocks Offering More Than Just Income
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
- Can Boxabl Turn Modular Homes Into AI Data Center Infrastructure?
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
